Insights

Global Presence SEQENS has 16 manufacturing plants and 9 R&D centers across Europe, North America, and Asia, providing ample opportunities for expanding sales reach in diverse markets.

Strategic Partnerships Recent partnerships with companies like Aether Industries, Holcim, and Univar indicate a proactive approach to collaborations, presenting potential cross-selling opportunities and access to new customer segments.

Innovative Solutions With a focus on developing tailor-made solutions and implementing cutting-edge technologies, SEQENS' ability to innovate presents a strong value proposition to attract customers seeking advanced pharmaceutical and specialty ingredients.

Expansion Initiatives The expansion of facilities in France and Massachusetts, along with significant R&D investments, showcases ambitious growth plans that could translate into increased sales volumes and customer acquisitions in key regions.

Acquisition History Being acquired by SK Capital Partners and aligning with a network of industrial companies offers potential synergies and cross-selling opportunities, leveraging collective expertise to drive sales growth and market penetration.

SEQENS Tech Stack

SEQENS uses 8 technology products and services including Google Analytics, QlikView, Atex, and more. Explore SEQENS's tech stack below.

Google Analytics

Analytics

QlikView

Business Intelligence

Atex

Content Management System

Oracle

Enterprise

Engagez

Event Management

ADP

Human Resource Management System

Microsoft

Miscellaneous

Google Tag Manager

Tag Management

SEQENS Email Formats	Example	Percentage
First.Last@seqens.com	John.Doe@seqens.com	84%
FLast@seqens.com	JDoe@seqens.com	14%
First.L@seqens.com	John.D@seqens.com	1%
FMiddleLast@seqens.com	JMichaelDoe@seqens.com	1%

SEQENS Email Formats

Example

Percentage

First.Last@seqens.com

John.Doe@seqens.com

84%

FLast@seqens.com

JDoe@seqens.com

14%

First.L@seqens.com

John.D@seqens.com

FMiddleLast@seqens.com

JMichaelDoe@seqens.com

Frequently Asked Questions

Where is SEQENS's headquarters located?

SEQENS's main headquarters is located at 21, Chemin de la Sauvegarde Écully, Auvergne-Rhône-Alpes 69130 FR. The company has employees across 5 continents, including EuropeNorth AmericaAsia.

What is SEQENS's official website and social media links?

SEQENS's official website is seqens.com and has social profiles on LinkedIn.

How much revenue does SEQENS generate?

As of July 2024, SEQENS's annual revenue reached $750M.

What is SEQENS's NAICS code?

SEQENS's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does SEQENS have currently?

As of July 2024, SEQENS has approximately 1.3K employees across 5 continents, including EuropeNorth AmericaAsia. Key team members include Chief Financial Officer And Chief Operations Officer: P. S.Chief Compliance Officer: A. B.Chief Procurement Officer: C. D.. Explore SEQENS's employee directory with LeadIQ.

What industry does SEQENS belong to?

SEQENS operates in the Pharmaceutical Manufacturing industry.

What technology does SEQENS use?

SEQENS's tech stack includes Google AnalyticsQlikViewAtexOracleEngagezADPMicrosoftGoogle Tag Manager.

What is SEQENS's email format?

SEQENS's email format typically follows the pattern of . Find more SEQENS email formats with LeadIQ.

When was SEQENS founded?

SEQENS was founded in 2003.

SEQENS

Pharmaceutical ManufacturingAuvergne-Rhône-Alpes, France1001-5000 Employees

SEQENS is a worldwide leader in pharmaceutical solutions and specialty ingredients. 

The group generates a revenue of 1.1 MM€ and operates 16 manufacturing plants and 9 R&D centers in Europe, North America and Asia. 3,300 employees contribute to the success of SEQENS, among which 350 scientists, engineers and experts who develop tailor-made solutions for our customers.

SEQENS is an integrated player offering a broad portfolio of active ingredients, pharmaceutical intermediates and specialty ingredients. We develop and industrialize the most demanding molecules, and rely on our ability to innovate, develop and implement the best available technologies.

Insights

Similar companies to SEQENS

Vertellus

BASF

Roche

Dow

Novasep

Evonik

Lonza

Sumitomo Chemical

Novartis

Mintek

SEQENS Tech Stack

Media & News

Aether Industries partners with Seqens group.

Seqens group partners with Holcim.

Seqens group partners with Univar.

Biophytis SA partners with Seqens group.

Seqens group expands facilities to France.

SK Capital Partners LP acquired Seqens group on Apr 8th '21.

Seqens group expanded facilities to Massachusetts, United States on Feb 28th '22.

SEQENS's Email Address Formats